Brazil: Hypera Pharma net revenue 2017, by category
net revenue of approximately 3.64 billion Brazilian reals, out of which 41 percent corresponded to prescription products. Meanwhile, 29 percent of the company's net revenue that year originated from biosimilar and generic medication.
In 2017, the Brazilian pharmaceutical company Hypera Pharma generated a